Trial
NCT03252093
Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABG
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Suburban Hospital
Condition
Coronary Artery Bypass Surgery
Intervention
Angiotensin-(1-7)
Why stopped
Funding ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-04